This strategic tie-up will use technology to reach out to patients in the remotest regions of the country
RaphaCure, healthtech company has entered into a strategic partnership with Madhavbaug (Vaidya Sane Ayurved Laboratories ), chain of clinics and hospitals in the cardiac care space leveraging the amalgamation of Ayurvedic treatments and modern medical science.
This strategic tie-up will use technology to reach out to patients in the remotest regions of the country.
Commenting on this strategic collaboration, Dr Rohit Sane, Madhavbaug’s Founder, MD & CEO said, “This tie-up is a giant leap for making non-invasive care accessible for masses in the remote regions of the country through Raphacure-Cognota technology platform.”
Jeyakumar, Founder and MD, RaphaCure said, “As we move ahead, RaphaCure & Madhavbaug (Vaidya Sane Ayurved Laboratories Ltd) will complement each other in taking the non-invasive cardiac care treatments to every nook and corner of the country. Leveraging our telemedicine platforms, Madhavbaug will expand its patient care reach further as we tap into each other’s network. With a great synergy in our operations and objectives, we will strive to take preventive cardiac care to the next level.”
Telemedicine adoption is growing at a rapid pace in India. A recent EY study estimates the market size to reach $5.5 billion by 2025.
Sanjeev Dahiwadkar, Founder & CEO, Cognota Healthcare added, “Indian healthcare ecosystem is digitalising at a rapid pace with telehealth seeing the highest adoption amid the pandemic. The collaboration between RaphaCure & Madhavbaug (Vaidya Sane Ayurved Laboratories Ltd) is a testimony to the fact that technology plays a crucial role in making this happen.”